Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relacorilant in hypercortisolism (GRADIENT)
NCT04308590Phase 3Completed
- Sponsor
- Corcept Therapeutics
- Start
- Jul 2020
- Primary completion
- Sep 2024
- Modality
- Orthosteric Ligands
- Countries
- 9
01
Overview
A Phase 3 trial of relacorilant in Cushing's syndrome, sponsored by Corcept Therapeutics. Started Jul 2020; status: completed.
02
Drugs
relacorilant
03
Conditions
Cushing's syndrome
Beyond the preview
Go deeper on NCT04308590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04308590.